Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21117276 | 1.00 | SRC (0.47) | SRCL3MBTL1TDP1CYP3A4TSHR | |
| SCHEMBL23349551 | 0.91 | CYP3A4 (0.44) | SRCL3MBTL1TDP1CYP3A4TSHR | |
| SCHEMBL21119420 | 0.89 | CYP3A4 (0.46) | SRCL3MBTL1TDP1CYP3A4TSHR | |
| SCHEMBL23349397 | 0.84 | SRC (0.35) | SRCL3MBTL1TDP1CYP3A4TSHR | |
| SCHEMBL28913403 | 0.83 | SRC (0.38) | SRCL3MBTL1TDP1TSHRKDM4E | |
| Triphenyl Phosphate SCHEMBL29001490 | 0.83 | SRC (0.58) | SRCL3MBTL1TDP1CYP3A4TSHR | |
| Triphenyl Phosphate SCHEMBL1207087 | 0.83 | SRC (0.58) | SRCL3MBTL1TDP1CYP3A4TSHR | |
| Triphenyl Phosphate SCHEMBL18116 | 0.82 | SRC (0.64) | SRCL3MBTL1TDP1CYP3A4TSHR | |
| Triphenyl Phosphate SCHEMBL28557783 | 0.82 | SRC (0.64) | SRCL3MBTL1TDP1CYP3A4TSHR | |
| Triphenyl Phosphate SCHEMBL483692 | 0.82 | SRC (0.64) | SRCL3MBTL1TDP1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111334800-A | Novel PCB micro-etching solution and preparation method thereof | 信丰正天伟电子科技有限公司 | 2020-06-26 | — | — | CN | claimed |
| EP-3684374-B1 | 4'-FLUORO-2'-METHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION | RIBOSCIENCE LLC (US) | 2025-07-30 | — | — | EP | disclosed |
| CN-119153778-A | Nonaqueous electrolyte and lithium ion battery comprising same | 湖州昆仑亿恩科电池材料有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-116444479-B | Preparation method of high optical purity L-lactide | 扬州大学 | 2024-08-02 | — | — | CN | disclosed |
| WO-2024017380-A1 | TRICYCLIC-CONTAINING MACROCYCLIC COMPOUND AND USE THEREOF | 南京明德新药研发有限公司 | 2024-01-25 | — | — | WO | disclosed |
| CN-111194217-B | 4 '-fluoro-2' -methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication | 里伯赛恩斯有限责任公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-116981672-A | Macrocyclic compounds as CFTR modulators | 爱杜西亚药品有限公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-3744723-B1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE MACROCYCLIC COMPOUND | SHENZHEN TARGETRX INC (CN) | 2023-10-18 | — | — | EP | disclosed |
| EP-3760632-B1 | PYRAZOLOPYRIMIDINE DERIVATIVE AND USE THEREOF | Simcere pharmaceutical co ltd (CN) | 2023-07-19 | — | — | EP | disclosed |
| CN-116444479-A | Preparation method of high optical purity L-lactide | 扬州大学 | 2023-07-18 | — | — | CN | disclosed |
| US-20140295566-A1 | CARBOHYDRATE-LIGAND CONJUGATES AND THEIR APPLICATION FOR THE ANALYSIS OF CARBOHYDRATE-PROTEIN INTERACTION | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-10-02 | — | — | US | disclosed |
| US-8765384-B2 | Carbohydrate-ligand conjugates and their application for the analysis of carbohydrate-protein interaction | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20100279936-A1 | SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2010-11-04 | — | — | US | disclosed |
| EP-2061449-A1 | SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES | Leo Pharma A/S (DK) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008019690-A1 | SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2008-02-21 | — | — | WO | disclosed |
| US-7320867-B2 | Linker compound, ligand, and producing method thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-01-22 | — | — | US | disclosed |
| US-20070287195-A1 | Carohydrate-Ligand Conjugates and Their Application for the Analysis of Carbohydrate-Protein Interaction | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-12-13 | — | — | US | disclosed |
| EP-1726596-A1 | SUGAR CHAIN LIGAND COMPOSITE AND METHOD OF ANALYZING PROTEIN WITH THE LIGAND COMPOSITE | Japan Science and Technology Agency (JP) | 2006-11-29 | — | — | EP | disclosed |
| US-20060030699-A1 | Versatile linker compound and ligand, and method for preparation thereof | NATIONAL UNIVERSITY CORPORATION KAGOSHIMA UNIVERSITY (JP) | 2006-02-09 | — | — | US | disclosed |
| EP-1538156-A1 | VERSATILE LINKER COMPOUND AND LIGAND, AND METHOD FOR PREPARATION THEREOF | Japan Science and Technology Agency (JP) | 2005-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100279936-A1 | SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES | C1R, C3AR1, PTH1R | SRC 2379/4885L3MBTL1 2017/4885TDP1 4767/4885 |
| US-20070287195-A1 | Carohydrate-Ligand Conjugates and Their Application for the Analysis of Carbohydrate-Protein Interaction | CA11, CNPY3, CACYBP | SRC 1614/4885L3MBTL1 2698/4885TDP1 4792/4885 |
| US-20140295566-A1 | CARBOHYDRATE-LIGAND CONJUGATES AND THEIR APPLICATION FOR THE ANALYSIS OF CARBOHYDRATE-PROTEIN INTERACTION | CA11, CA14, OSTC | SRC 1298/4885L3MBTL1 2940/4885TDP1 4844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.